About this trial
Mild Cognitive Impairment (MCI) is defined as an impairment in a single cognitive function, usually memory, other than normal cognitive decline with age, that does not fulfil dementia criteria. Finger movements have been shown to stimulate the sensory-motor and cognitive parts of the cerebral cortex, as well as the supplementary motor area, Broca's area, premotor cortex, and prefrontal cortex, all of which contribute to movement skills. Asymmetrical hand and finger movements done concurrently were proven to improve cognitive processes and cerebral blood flow more than movements performed with one hand.
Eligibility criteria
Qualifiers
Participants who are between 50-75 years of age
Individuals diagnosed with MCI by a geriatrician according to DSM-5 criteria,
Who has the Montreal Cognitive Assessment score between 13-26,
Who has the Quick Mild Cognitive Impairment screen score between 48-67,
Disqualifiers
Participants who have any musculoskeletal disorders that may cause balance and gait disorders,
Who have central or peripheral neurological diseases (eg. stroke, Parkinson's disease or polyneuropathies),
Who are using psychiatric drugs that may affect psychiatric disease and/or cognitive performance (Using nonsteroidal anti-inflammatory drugs more than three times a week, which may affect cognitive functions, using gingko biloba and antioxidant supplements (for example, coenzyme Q10 and alpha-lipoic acid)),
Who has daltonism and
Trial design
Treatments tested in this trial
- Bimanual Exercise
- Finger Exercise
- Virtual Reality